RISANKIZUMAB-RZAA
3 NDCs across 1 manufacturer|0 Generic,3 Brand
Risankizumab-rzaa is available as 3 NDCs from 1 manufacturer (0 generic, 3 brand), with NADAC prices from $9679.49 to $22942.37 per unit — a 58% spread. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
3
0G / 3B
Manufacturers
1
competing in market
Price Spread
$9679.49 – $22942.37
Up to 58% savings
7d Activity
avg -0.1% WoW · of 3 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Frequently Asked Questions
How many Risankizumab-rzaa products are on the market?
The Risankizumab-rzaa drug market contains 3 NDCs from 1 manufacturer — 0 generic and 3 brand products.
What is the price range for Risankizumab-rzaa?
NADAC reference prices for Risankizumab-rzaa range from $9679.4921 to $22942.3716 per unit, a 58% spread between the cheapest and most expensive product.
Which manufacturers make Risankizumab-rzaa?
1 manufacturer lists Risankizumab-rzaa in NADAC. Ranked by number of NDCs, the largest are AbbVie Inc. (3).
How has the price of Risankizumab-rzaa changed recently?
Over the past 7 days, 0 Risankizumab-rzaa NDCs rose and 1 fell, with a market-wide average change of -0.1%.
Manufacturer Breakdown
1 manufacturer producing RISANKIZUMAB-RZAA
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
SKYRIZI 150 MG/ML SYRINGE | $22942.3716 per ML | — |
SKYRIZI 150 MG/ML PEN | $22710.1121 per ML | -0.12% |
SKYRIZI 360 MG/2.4 ML ON-BODY | $9679.4921 per ML | — |